Nuvation Bio Ownership | Who Owns Nuvation Bio?
Nuvation Bio Ownership Summary
Nuvation Bio is owned by 64.56% institutional investors, 18.59% insiders, and 16.85% retail investors. Fmr is the largest institutional shareholder, holding 15.22% of NUVB shares.
NUVB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nuvation Bio | 64.56% | 18.59% | 16.85% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 51.99M | 15.22% | $223.04M |
| Decheng capital | 25.95M | 7.60% | $111.34M |
| Blackrock | 16.24M | 7.41% | $47.41M |
| Blackrock funding, inc. /de | 25.10M | 7.35% | $107.68M |
| Vanguard group | 15.56M | 4.54% | $139.38M |
| Omega fund management | 8.08M | 2.37% | $34.67M |
| Laurion capital management lp | 7.82M | 2.29% | $33.56M |
| State street | 6.78M | 1.99% | $29.11M |
| Geode capital management | 5.86M | 1.72% | $25.16M |
| Duquesne family office | 4.54M | 1.33% | $19.48M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Omega fund management | 8.08M | 21.25% | $34.67M |
| Decheng capital | 25.95M | 16.84% | $111.34M |
| Tanaka capital management | 685.11K | 4.56% | $2.54M |
| Edbi pte | 1.27M | 3.58% | $3.38M |
| Knoll capital management | 1.50M | 3.57% | $6.43M |
| Octagon capital advisors lp | 2.63M | 1.48% | $9.74M |
| Laurion capital management lp | 7.82M | 1.46% | $33.56M |
| Ghost tree capital | 1.15M | 1.05% | $3.36M |
| Act capital management | 290.00K | 0.98% | $1.24M |
| Redmile group | 3.15M | 0.90% | $13.53M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Duquesne family office | 4.54M | 0.58% | 4.54M |
| Blackrock | 16.24M | 0.00% | 3.71M |
| American century companies | 2.90M | 0.01% | 2.86M |
| Two sigma investments, lp | 2.68M | 0.01% | 1.95M |
| Citadel advisors | 2.07M | 0.00% | 1.93M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -19.21M |
| Octagon capital advisors lp | 2.63M | 1.48% | -5.06M |
| Bioimpact capital | - | - | -4.62M |
| Aisling capital management lp | - | - | -2.96M |
| Abrams capital management | 1.27M | 0.12% | -2.54M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Duquesne family office | 4.54M | 0.58% | 4.54M | $19.48M |
| Vanguard fiduciary trust | 1.59M | 0.00% | 1.59M | $6.83M |
| Ghost tree capital | 1.15M | 1.05% | 1.15M | $3.36M |
| Silvercrest asset management group | 724.38K | 0.02% | 724.38K | $3.11M |
| Tanaka capital management | 685.11K | 4.56% | 685.11K | $2.54M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -28.00 |
| Clearstead advisors | -30.00 |
| Srs capital advisors | -36.00 |
| Bare financial services | -53.00 |
| Parkside financial bank & trust | -80.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 235 | 3.07% | 220,513,894 | 4.35% | 64 | 1.70% | 136 | 5.43% | 58 | -13.43% |
| Dec 31, 2025 | 96 | -54.07% | 35,002,980 | -84.13% | 10 | 0.24% | 53 | -57.60% | 28 | -40.43% |
| Sep 30, 2025 | 76 | -56.82% | 27,947,807 | -87.00% | 8 | 0.21% | 42 | -64.71% | 17 | -39.29% |
| Jun 30, 2025 | 184 | 14.29% | 224,710,788 | 8.38% | 65 | 1.76% | 122 | 64.86% | 30 | -42.31% |
| Mar 31, 2025 | 160 | - | 207,338,637 | 4.87% | 61 | 1.17% | 74 | -19.57% | 51 | 45.71% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 17, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell | $184.28K |
| Apr 17, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | $251.00K |
| Apr 06, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell | $903.56K |
| Dec 01, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | $1.17M |
| Nov 26, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | $80.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | - |
| 2025 Q2 | 11 | 1 |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | 1 |
NUVB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools